Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
Insider Trades
|
Turnaround Potential
1322.7000
11.30
(
0.86
%)
NSE
Sep 18, 2025
15:31 PM
29.68% Gain from 52W Low
Volume:
822.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
01 Nov 2022
Insider Trades
1322.70
0.86%
Result Update:Dr Reddys Labs
Buy:
Dr. Reddy's Laboratories Ltd.
by
Axis Direct
Target: 5000
Target
Axis Direct
We recommend a BUY rating on the stock with a TP of Rs 5,000/share.
Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 11 Sep, 2025.
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market closes higher, Ugro Capital gets RBI nod to acquire Profectus Capital
Trendlyne Marketwatch |
18 Sep 2025, 04:03PM
Bull run fizzles out: Multibagger count in Indian equities falls
The Baseline |
18 Sep 2025, 03:38PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021, 11:13AM